Le Lézard
Classified in: Health
Subject: BFA

Multimedia Now Available: Learn More About Light Chain (AL) Amyloidosis and a New Treatment Option


HORSHAM, Pa., Jan. 15, 2021 /PRNewswire/ -- Learn about light chain (AL) amyloidosis and a new treatment option for this rare and serious blood cell disorder.

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8829551-janssen-light-chain-al-amyloidosis/

Media contacts:
Bernadette King
Phone: +1 215-778-3027

Satu Glawe
Phone: +49 172-294-6264

Investor Relations:
Jennifer McIntyre
Phone: +1 732-524-3922

U.S. Medical Inquiries:
+1 800-526-7736

Janssen_Biotech_Logo

 

 

SOURCE Janssen Pharmaceutical Companies of Johnson & Johnson


These press releases may also interest you

at 11:37
According to data from the CDC, the construction industry has the highest overdose death rate across all industries1. Construction workers are five times more likely to die by suicide than safety-related issues2. BTEA is uniting the union...

at 11:35
A2 Biotherapeutics, Inc. (A2 Bio) a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells, today announced the acceptance of three posters for presentation...

at 11:28
Qualitas Dental Partners proudly announces its partnership with the foremost oral surgery group in New England, furthering its commitment to deliver patient-centric dental care across the region....

at 11:25
MAKO Medical, a leader in healthcare diagnostics and laboratory services, is honored to announce its partnership with Rebuilding Together, a renowned nonprofit organization focused on repairing homes, revitalizing communities, and rebuilding lives....

at 11:20
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Company's request for an extension of its previously announced stay of proceedings under the Companies' Creditors Arrangement Act (the "CCAA") was heard before the Ontario...

at 11:15
The Human Animal Bond Research Institute (HABRI) today announced a new grant for research that investigates the contribution of pet dog ownership to resilience and well-being in adolescent children of military families. This grant was awarded to a...



News published on and distributed by: